• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>St. Jude Medical

St. Jude Medical

Principal LifeTime 2050 R2 PTENX 2 Star

Last Price$14.08Day Change (%)-0.07%
Open Price$14.08Day Change ($)-0.01
Day Range14.08–14.0852-Week Range12.41–14.12

As of Sat 02/24/2017 | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Carl Icahn Takes Stake in Bristol-Myers Squibb -- 2nd Update

    Carl Icahn Takes Stake in Bristol-Myers Squibb -- 2nd Update

  2. New Pressure on Drug Giant -- WSJ

    New Pressure on Drug Giant -- WSJ

  3. Global $26.6 Billion BioMEMS devices Market Analysis & Trends Report 2017-2025: Market is Poised to Grow at a CAGR of Around 26.1% - Research and Markets

    Global $26.6 Billion BioMEMS devices Market Analysis & Trends Report 2017-2025: Market is Poised to Grow at a CAGR of Around 26.1% - Research and Markets

  4. Global Cardiology Surgical & Interventional Cardiology Devices Market (2017-2023) - Insights, Analysis, Market Shares & Forecast - Research and Markets

    Global Cardiology Surgical & Interventional Cardiology Devices Market (2017-2023) - Insights, Analysis, Market Shares & Forecast - Research and Markets

  5. $19.60 Billion Prosthetic Heart Valve Market: Global Industry Analysis & Opportunity Assessment, 2016-2026 - Research and Markets

    $19.60 Billion Prosthetic Heart Valve Market: Global Industry Analysis & Opportunity Assessment, 2016-2026 - Research and Markets

  6. Our Outlook for the Credit Markets

    Widening investment-grade credit spreads and rising interest rates lead to losses.

  7. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

  8. January 2010 Mutual Fund Red Flags

    There's steep price for no growth in these portfolios.

  9. Together We Stand, Divided We Fall?

    Each succeeding bailout entangles the global financial system even further.

12

©2017 Morningstar Advisor. All right reserved.